FTC Closes Antitrust Probe Of Allergan's Acular Drug
The Federal Trade Commission has officially closed its antitrust investigation into accusations that Allergan tried to block generic competition for its Acular eye drug....To view the full article, register now.
Already a subscriber? Click here to view full article